The mouse mammary tumor virus long terminal repeat (MMTV-LTR) participates In the control of gene expression by providing a series of Important DNA binding sites at which trans-acting factors Interact. Among these factors are the steroid receptor, nuclear factor I (NFI) and the TATA box factor (TFIID). The binding of these proteins facilitates the assembly of a transcriptlonally competent complex, that includes RNA polymerase II, and activates the expression of juxtaposed genes In els. A particular DNA sequence, distinct from previously Identified regulatory elements, was found In the present study to activate gene expression In trans. The sequence is located between nucleotides + 3 and + 43 near the 3' terminus of the LTR. This sequence binds a protein that may actively repress the expression of genes that are not located Immediately In els. This protein was purified by Ion exchange chromatography and has an approximate molecular weight of 31,000 daltons, as judged by SDS -PAGE. Gel retardation experiments reveal that progressively larger protein-DNA complexes are formed when the amount of this factor is increased relative to the DNA binding site. Futhermore, this protein was found to preferentially aggregate DNA molecules containing the LTR sequence between bases + 3 and + 43. These results reveal the existence of a unique modulatory role for the LTR in regulating gene expression In trans.
INTRODUCTION
The long terminal repeats (LTR) of many retroviruses, including the mouse mammary tumor virus (MMTV), contain a number of DNA sequences that participate in the regulation of viral gene expression. The transcriptional control exerted by these elements is augmented by the binding of many transacting factors. For example, promoters from MMTV are activated by steroid hormones in a process involving the interaction of hormone receptors with particular DNA sites (1). Some of these elements were determined by straight-forward deletion analysis of the LTR; 200 base pairs 5' to the transcription start site confers hormone inducibility to heterologous promoters (2) . The binding of the hormone receptor, in all likelihood, facilitates the binding of nuclear factor I (NFI) and the TATA box binding factor TFIID (3, 4) . This interaction, in turn, promotes the binding of RNA polymerase II and the onset of transcription.
As in many other cases, DNA binding studies addressing nucleoprotein complex formation utilized the LTR template and purified, transacting factors. The results, however, did not simulate the in vivo effect of hormone administration on the interaction of NFI with its cognate binding site (see 18 and references therein). These authors concluded that such a difference was a reflection of the packaging of the LTR into chromatin and thus the alteration in site accessibility. Previously, Richard-Foy and Hager (5) had demonstrated that the LTR (MMTV) and in particular the hormone response element (HRE), is covered by precisely positioned nucleosomes that could sterically hinder the binding of transacting factors. The importance of these results were revealed when Perlman and Wrange (6) showed that the HRE is assembled into chromatin in vitro with a positioning predicted by in vivo studies. In a series of elegant experiments, Beato and his colleagues (7) demonstrated that the hormone-receptor complex or the activated receptor can bind to the HRE, wrapped in a nucleosome, facilitating the accessibility of NFI to the DNA. Hence, a repressive but manipulable role for nucleosome structure was established on the promoter regions of the MMTV-LTR.
The majority of investigations addressing the mechanism of transcriptional enhancement by the LTR have utilized templates in which the LTR was contiguous with the inducible gene, i.e. in cis. Recent studies, however, suggested that the LTR can stimulate expression of genes that are hormonally non-responsive and do not require the binding of an activated receptor (8) . These investigators showed that the MMTV-LTR enhanced tRNA gene expression catalyzed by a Xenopus laevis cell-free extract (S-150) when the LTR and the gene were on different DNA molecules, i.e. in trans. The S-150 extract catalyzes gene expression from templates assembled into chromatin (9) and dependent on the initial topology of the exogenously added template (10, 11) . DNA foot-printing analysis of the LTR with the S-150 extract did not reveal clear evidence for hormone receptor binding to the HRE (Li and Kmiec, unpublished observations). The data suggested the possibility that other transacting factors play a role in governing the enhancement of tRNA gene expression. Yet, no other distinct binding sites were protected, suggesting further that a site-specific DNA binding protein may not be involved directly in this phenomenon. Hence, we set out to identify the sequence responsible for trans-activation and to purify the factors that contribute to this enhancement. In this report, we outline the results of our study.
MATERIALS AND METHODS Preparation of LTR deletions
The long terminal repeat was extracted from plasmid pCL-1 (12) by digestion with EcoRI. The fragment is 1489 nucleotides long, although the LTR itself is 1332 nucleotides in length (13) . Deletions of the LTR, cloned into EcoRI of pUC-18, were made based on the procedure developed by Henikoff (14) in which exonuclease HI (Exo ID) specifically digests DNA from a BamHIcleaved end. Deletions were made at predetermined intervals by removing timed aliquots from die reaction and the extent of deletions was verified by DNA sequence analysis. Intact and deletion clones containing the LTR were radioactively labeled with I
32 ?] by the method of Razvi et al. (15) . Plasmid pXltfmetj (containing the tRNA gene) and pXlks-5' DNA (containing the LTR 644 bp from the 5' end of the tRNA gene) are described by Li and Kmiec, (8) . Plasmid pXltfmeti contains a single copy of the genomic repeat of the Xenopus laevis mediionine tRNA gene (gene plus spacer) cloned into plasmid pUC-18. The entire fragment is 836 base pairs in length. Plasmid pXlks-5' consists of the tRNA genomic repeat and the entire long terminal repeat (1332 nucleotides). The clone harbors these two fragments in the vector pUC-18 in the following orientation: 5'-LTR fragment (1332)-tRNA fragment (836>3'. All DNA was used in the linear form after restriction digestion and organic extraction.
Transcription assays
The tRNA gene repeat extracted from plasmid pXltfmet! was used as the transcription template. The LTR fragments used in this study were generated by restriction digest of plasmid pXlks-5' or from Exo HI deletions. Ah" fragments were purified by electrophoresis through low melting point agarose and subsequent organic extraction. Transcription assays were carried out as described by Sekiguchi et aL (10) using a DNA template to extract ratio of 4:1 (nanograms to microliters). Stimulant to template DNA ratios were calculated on a molecule per molecule basis and are given as integral values in each figure (generally held at a ratio of 2:1). Transcripts were analyzed by electrophoresis in 10% acrylamide gels (17 cm) containing 6 M urea at 200 Volts for 3 hours, followed by autoradiography.
Purification of inhibitor factor 1 (Dl) from S-150 extract RESULTS The Xenopus S-150 cell free extracts were isolated according to the method of Glikin et aL (9) with the modification of Sekiguchi et aL (10) . The S-150 extract was precipitated first with (NH,Ŝ O 4 to 30% saturation by slow addition over a 2 hour period with constant stirring at 4°C. This solution was allowed to stir for an additional 1 hour at 4°C after which time it was centrifuged in 15 ml glass corex tubes for 30 minutes in a Sorval SA-600 rotor at (8000Xg). The supernatant was brought to 60% saturation by the addition of (NH^ SO 4 and the process repeated. The pellet of the 60% precipitation was resuspended in 10 ml of G buffer (30 mM Tris HC1, pH 7.9, 90 mM KC1, 10 mM sodium (3-glycerolphosphate, 1 mM DTT and 2 mM EGTA) and dialyzed for 8 hours against G buffer wim hourly changes. The sample was applied to a Heparin-agarose column (2 ml bed volume per 5 ml S-150) and the column washed with 20 ml of G buffer. Routinely, 0.75 mg of protein were added per ml of resin and the S-150 was diluted with G buffer to obtained this ratio. All columns were run at a 0.3 ml/minute pace using a Biorad chromatography system. A 30 ml linear gradient of NaCl was then applied to the column starting with 0.25 M NaCl and ending with 1.0 M NaCl (60 tubes, with 0.5 ml/tube were collected). The protein peak, as judged by absorbance at 280 X, was collected and dialyzed extensively against G buffer. Protein fractions that demonstrated DNA binding activity were applied to an Affigel Blue column (0.3 ml bed volume) and washed with 3 ml of G buffer containing 0.25 M NaCl. This was followed by two 5 ml bumps of G buffer containing 0.5 M and 1.0 M NaCl respectively. Fractions of the 0.5 M and 1 M NaCl bumps (1 ml each) were collected and analyzed individually for specific DNA binding activity. The active fractions were eluted at a NaCl concentration of 0.5 M.
These fractions were dialyzed against G buffer and stored at -80°C for at least 6 months without loss of activity.
Gel retention assays, aggregation assays and Western blotting
The binding of the purified IF 1 with labeled LTR was monitored by gel retention assays. The [ 32 P]-labeled DNA template (1 ng or as otherwise indicated) was incubated with 10 /tl of the appropriate Heparin fraction or Affigel-Blue fraction at 26°C in die presence of 3 mM MgCl 2 in G buffer. After 60 minutes, the sample was directly loaded onto a 1 % agarose gel in Tris-glycine buffer, or 1XTAE buffer and electrophoresis was carried out at 100 Volts for 3-4 hours with and without recirculation. Band shifts were visualized by autoradiography. SDS-poly acrylamide gel electrophoresis was carried out on 12.5% slab gels using the buffer system of Laemmli (16) and stained with Comassie blue or silver. DNA aggregation was analyzed by reacting die [^PJ-labeled DNA template with varying amounts of the Affigel-Blue fraction for 60 minutes at 26°C. The 25 /tl reaction mixtures were men centrifuged in an Eppendorf microfuge (5415C) at 7,500 Xg for 10 minutes and the supernatants and resuspended pellets (25 /U G buffer) added to scintillation fluid for determination of radioactive partitioning. Western blot analysis was carried out according to DiMario and Gall (17) using monoclonal antibodies raised against amphibian histone HI. These antibodies, a kind gift from Dr P.DiMario (LSU), were used at the 1:50 dilution suggest by DiMario et al. (18) . Primary antibodies were detected immunochemicaUy by Vectastain ACC Kit anti-mouse IgG (Vector Laboratories, Burlingame, CA).
Previously, our laboratory found diat in vitro transcription of a Xenopus tRNA gene by the Xenopus S-150 cell-free extract was influenced significantly by the topological state of the DNA template (10, 11) . Superhelical DNA templates were transcribed by RNA polymerase Hi at a higher rate than were their linear counterparts. Li and Kmiec (8) demonstrated that the level of transcription originating from linear templates containing die tRNA gene and packaged into chromatin was stimulated 10-fold by die inclusion of the MMTV long terminal repeat (LTR) in die reaction mixture. In the present study we confirm and extend dieir observation by examining the enhancement of expression as a function of time. The LTR was incubated with a DNA fragment containing the tRNA gene and its genomic repeat spacer (excised from plasmid pXltfmeti). This template constitutes the tRNA repeat devoid of exogenous plasmid sequences and is used in each experiment described in this manuscript. The reactions containing the indicated DNA fragments and the Xenopus S-150 extract were incubated for various times which included a 20 minutes pulse with [^PJa-GTP, CTP and UTP within the indicated time. An analysis of the transcriptional activity at each time point is displayed as Figure 1 . It is clear that the LTR stimulated the expression of the Xenopus tRNA gene in vitro, reiterating the early studies of Li and Kmiec (8) . Importantly, we demonstrate that transcriptional stimulation by the LTR occurs on a template containing the intact tRNA gene, but devoid of plasmid sequences.
The MMTV-LTR contains a large number of regulatory elements, some of which are known to enhance expression of juxtaposed genes (i.e. in cis). The phenomenon outlined in Figure  1 , however, reveals that the LTR can stimulate expression in trans. To identify the DNA sequence responsible for this enhancement, we made systematic deletions of the LTR and analyzed each DNA fragment for its capacity to enhance transcription. The long terminal repeat was extracted from plasmid pCL-1 (12) by digestion with EcoRI. The LTR was reduced progressively in size by exonuclease HI digestions and sequenced to verify length. The pertinent fragments obtained by this method are presented schematically in Figure 2A . For example, A910 indicates that 910 nucleotides of the intact LTR were deleted and thus the fragment contains 422 LTR base pairs. Each of these fragments was then co-incubated with the tRNA template at a molecular ratio of 5:1 in the presence of the S-150. After 2 hours, the reactions were terminated and the level of transcription from the template analyzed ( Figure 2B ). The stimulation of transcription by a DNA fragment containing sections of the LTR is observed through A1228, but no enhancement is seen if the next 40 bases are deleted (A 1268). Hence, it is probable that the DNA element responsible for the transcriptional enhancement we observe, exists within the region containing nucleotides 1228 and 1268. The nucleotide sequence, listed in Figure 2C , does not contain any known, consensus DNA binding sites (i.e. receptor binding sites, nuclear factor binding (NFT) sites or the TATA box). Additionally, this region is not overlapping with a previously identified negative regulation site (19) . It is located within the open reading-frame of the LTR, originating at nucleotide +3 and ending at +43. This region does contain one interesting feature at the sequence level. Beginning at nucleotide 1242 and continuing through base 1268 are a series of dinucleotides, wherein the latter nucleotide is almost invariably T. This unique repetition may function indirectly to modulate a cellular process.
In general, deletion analysis is informative with regard to the identification of regulatory sequences. It is, however, important to test significant sequences outside the context of the original clone. In addition, these types of constructs are of similar length, thus eliminating some artifactual explanations for the phenomenon. To address this issue, a series of DNA fragments containing LTR were subcloned into plasmid pUC-18. These clones were linearized, co-incubated with the tRNA gene and the transcriptional analysis is presented as Figure 3 . Surprisingly, many of the clones were found to stimulate a low level of tRNA gene expression, using linear pUC-18 as a reference DNA. Clearly, the DNA sequence between nucleotides 1228 (+3) and Figure  2 ) and 10 pi of the appropriate cotumn fraction was incubated in G buffer for 1 hour at 26°C. After this time, 10% glycerol was added, the sample loaded directly onto a 1 % agarose gel and electrophoresed for 3 hours at 100 Volts in Tris-glycine buffer without recirculation. The gel was dried and the fractions exhibiting DNA binding were visualized by autoradiography. C, control, no protein added; I, first group of fractions pooled; II, second group of pooled fractions.
1268 (+43) was the most effective in stimulating the response. Hence, we believe that this 40 base pair sequence does in fact contain a regulatory region that enhances transcription in trans. Since, the transcriptional stimulation occured in trans, we suspected that the protein was soluble in the cell-free extract and we decided to purify it. Our strategy employed ionic exchange chromatography with resins (Heparin-agarose and AfBgel-Blue) that structurally resemble DNA. The S-150 extract was prepared according to Sekiguchi et al. (10) and was precipitated serially with ammonium sulphate; first with 30%, then with 60% (see Materials and Methods). The resuspended pellet was dialyzed and applied to a Heparin -agarose column and the DNA binding activity was eluted with a salt gradient. Active fractions were dialyzed and subjected to Affigel-Blue chromatography and the DNA binding activity was again eluted by a gradient of increasing salt concentrations.
As an assay to detect DNA binding, we employed gel retardation. Routinely, the fraction was incubated with a linear DNA fragment (A 1228) containing the putative protein binding site in the presence of MgCl 2 -DNA binding was analyzed by electrophoresis through 1 % agarose in Tris -glycine buffer (see Materials and Methods). Figure 4 illustrates the DNA binding profile of the Heparin-agarose column. A series of fractions displayed DNA binding activity and two groups were subsequently pooled (I, fractions 8 -14; II, fractions [16] [17] [18] [19] [20] . Both fractions were dialyzed to remove salt and re-assayed. The data presented in Figure 4 reveal that a series of protein complexes with distinct mobilities were being formed. These data do not and cannot reveal the stoichiometry of protein-DNA complexation. Hence this characteristic of the protein(s) was addressed more directly by fixing the DNA concentration while increasing that of the protein ( Figure 5 ). Both fractions (I and H) showed a step-like pattern of DNA binding, indicating the possible presence of higher order structure or DNA aggregation. In addition, both fractions displayed similar patterns of nucleoprotein complex formation with regard to the migration position of these complexes after electrophoresis. Hence, we proceeded with the furthur purification of fraction I onto the Affigel-Blue column. After the fraction was loaded, the column was washed with a buffer containing 0.25 M NaCl followed by elution with buffers containing 0.5 M and 1.0 M NaCl respectively. One ml fractions of the 0.5 M and 1.0 M NaCl bumps were collected and analyzed individually for DNA binding activity. As illustrated in Figure 6A , DNA binding is observed in fractions 4, 5, 6, 7 and 8. The active fractions from the AfBgelBlue column were subjected to SDS-PAGE and the protein profile displayed as Figure 6B . A major band migrating at an approximate molecular weight of 31,000 daltons is visible and corresponds to the binding activity. We have tentatively identified this band as Inhibitor Factor 1 (IF1). Further purification did not achieve separation of any additional proteins while a dramatic loss in activity occurred. . After 1 hour, 10% gh/cerol was added and the samples loaded directly onto a 1 % agarose gel. Electrophoresis was carried out at 100 volts for 3 hours and DNA retardation visualized after autoradiography. C, no protein added; integers represent sequential fractions (1 ml). B. SDS-PAGE was carried out on the Affigel-Blue fractions 3 through 10 using a 6% stacking gel and 15% resolving gel according to Laemmli (16) . The DNA sequence specificity of the IF 1 binding reaction was tested using specific and nonspecific oligonucleotides. IF1 was incubated with three oligo templates containing the putative specific binding site (+3 to +43) or sequences flanking this site (-40 to 0, flank L; +45 to +95, flank R). DNA binding was assessed by the gel retardation assay. As seen in Figure 7A , the specific oligo is bound preferentially by low levels of the IF 1 preparation. Reduced levels of IF1 were used to avoid DNA aggregation and to gain a more complete understanding of binding preference. The left and right flanking sequences (relative to die specific +3/+43 sequence) are bound less efficiently. Interestingly, the right side sequence +45 to +85, is bound to a greater extent than the left flanking sequence. Although there is no significant homology between the +3/+43 and +45/+85 fragments, these results suggest the possibility of a hierarchy of binding sites. This notion is consistent with the fact that the tRNA gene, used as the transcription template and repressed by IF1, does not contain a +3/+43 binding element. The preferential binding exhibited by IF1 was also demonstrated by challenging the DNA-IF1 complex with specific or nonspecific templates. EF1 was bound to the pPJ-labeled +3/+43 sequence for 30 minutes followed by the addition of increasing concentrations of either +3/+43 (specific) or +45/+85 (nonspecific) unlabeled oligos. As displayed in Figure 7B , the +3/+43 oligonucleotide began to disrupte the nucleoprotein complex at a 7:1 molecular ratio (7 nanograms of competitor), completely destroying it at a 10:1 (10 nanograms of competitor) ratio. Only at 35 nanograms of nonspecific competitor did the IFH+3/+43) complex become disrupted. This gel was overexposed in order to detect any subtle changes in complex formation as a function of the presence of competitor DNA. We have not been able as of yet to define binding specificity by DNA footprinting techniques. In all cases, the DNA fragment was either extremely difficult to digest (at 6 id of the S-150 extract and 32 nanograms of A1010 DNA were incubated at 26°C. After the indicated time, the transcriptional activity of each sample was analyzed by addition of a mixture containing [^PJot-GTP and gel electrophoresis as previously described. A1010, the 322 base pair fragment coincubated with the tRNA gene; no addition, no A1010 or IF1 added; A1010 + IF1, A1O10 was prebound by 10 >d of IF1 for 60 minutes at 26°C prior to addition to the transcription assay mix; tRNA, position of tRNA transcript. Reaction mixtures (25 /d) containing 0.25 nanograms of pPJ-labeled DNA (as indicated) and varying amounts of IFI were brought to a total volume of 25 id with G buffer and were incubated at 26°C for 1 hour. After this time, the mixtures were centrifuged at 7,5OOxg for 10 minutes (see Materials and Methods) and the supematants carefully removed. The pellets were incubated at 37°C for 10 minutes after addition of 25 /il of G Buffer. Both pellet (p) and supematants (s) were counted in a scintillation counter to determine the partitioning of the radioactive DNA. The percentage in each fraction was calculated based on total input counts which vary due to different DNA specific activities. These numbers represent the averages of 4 independent experiments and the standard deviation for each set (total, 100%) is indicated for the pellet fraction.
high protein levels) and often remained near the top of the gel or no specific footprint was detected.
We tested the capacity of the purified protein to aggregate DNA by measuring the formation of insoluble complexes. IFI was incubated with different types of DNA under normal reaction conditions and after 30 minutes, the mixture was centrifuged at 7,500xg for 10 minutes in an Eppendorf microcentrifuge (see Materials and Methods). The supernatant was removed carefully and the pellet was resuspended in G buffer. Both samples were analyzed by scintillation counting to determine the partitioning of the DNA and Table I illustrates the results. In all cases, IFI was found to partition the DNA into the insoluble pellet form.
Iff tRNA F^jure 9. IFI does not cross-react with antibodies directed against histone HI. A. Monocional antibodies directed against amphibian histone HI (ata 1:50 dilution, see Materials and Methods) were blotted onto an SDS-protein gel containing calf thymus histone HI as a positive control (1 ng) (lane 1) and 2 ^g of purified IFI (lane 2). Cross-reactivity was detected by a secondary antibody raised against mouse IgG. M, refers to molecular weight markers, the positions of which were visualized by using pre-stained standards during SDS-PAGE. These colors are lost when the gel is transferred. B. Two sets of reaction mixtures (20 id) containing 1 nanogram of the [ 32 P]-labeled -H3/+43 specific oligonucleotide binding site were incubated with 3, 5 or 10 fd respectively of IFI at 26°C. After 1 hour of incubation, grycerol (10%) was added to one set of tubes while anti-histone HI antibodies (1:50) were added to the other set and incubation continued for 2 hours. Glycerol was then added to these samples and both sets were electrophoresed through 1 % agarose for 3 hours at 100 Volts followed by autoradiography. Left panel, no antibody addition; right panel, antibodies added; C, no IFI added. C. Reaction mixtures (10 id) containing 25 nanograms of the tRNA gene template, 6 id of the S-150 extract and where indicated, 32 nanograms of A1010 DNA were incubated at 26-C. After 2 hours, the transcriptional activity of the mixtures was determined as described in Materials and Methods. To some reaction mixtures (+ A1010/+aHl), anti-histone HI antibodies (1:50) were added at the start of the stimulated reaction. In other cases A1010/+aHl), the antibodies (1:50) were preincubated with the S-150 extract for 2 hours prior to the start of the reaction. As a control, the + A1010 reaction mixture was incubated at 26°C without either the tRNA gene template or A1010 for 2 hours. Finally, -A1010/+ a HI* indicates a reaction mixture where the antibodies were added at the same time as the tRNA gene template (reaction starting point). tRNA transcript, position of tRNA transcript It is clear, however, that templates containing the 40 base pair sequence from nucleotide 1228 to 1268 are rendered insoluble with lower protein concentrations. In control experiments, histone HI showed no preference for template aggregation, precipitating each labeled DNA to approximately the same extent (data not shown).
We next analyzed the influence that prebound BF1 has on the capacity of A1010 DNA to enhance gene expression in trans. IFI was prebound to clone A1010 (which contains two concensus GRE'S) and then was incubated with the tRNA gene and the S-150 extract for the indicated times. The transcriptional activity of the tRNA gene was measured (Figure 8 ). The addition of A1010 to the reaction mix enhanced transcription. In contrast, the absence of A1010 reduced transcriptional activity of the tRNA gene. When A1010 was prebound by IFI, however, only a small level of gene enhancement was once again observed. These data suggest that the removal of the binding site for IFI (by prebinding with purified IFI) on the A1010 template may have prevented it from capturing the inhibitory factor(s), which were then free to repress the tRNA gene expression. The addition or binding of IFI to A1010 did not alter the physical nature of the template (data not shown).
Inhibitor factor 1 displays some characteristics that are similar to those of histone HI. To determine if IFI is, in fact, Xenopus histone HI, monoclonal antibodies directed against amphibian histone HI were used in a Western blot analysis. As seen in Figure 9A , calf thymus HI histone, used as a control, was recognized by anti-histone HI antibodies quite readily. This antibody also recognizes histone HI and HI-like proteins from a variety of species including Xenopus (17, 18) . IFl did not crossreact with these antibodies nor with polyclonal antibodies generated in rabbits. The anti-Hl antibodies did not cause a supershift in a gel retardation assay which measures complex formation between IFl and the specific +3/+43 oligonucleotide probe ( Figure 9B ). In this experiment, increasing amounts of IFl were used for the gel retardation assay with an excess of antibody and we never observed a supershift of the IF1-DNA nucleoprotein complex. Since the results presented in Figure 8 suggested that A1010 prebound by IFl does not support enhancement of tRNA gene expression, we tested the effect of anti-Hl antibodies in a transcription reaction. The results are displayed in Figure 9C . In the absence of the A1010 DNA fragment, a low level of tRNA gene expression in observed whereas, in its presence, transcription of the tRNA gene was elevated. The co-addition of anti-Hl antibodies to a reaction containing A1010 did not influence tRNA gene expression and the sole addition of antiHl antibodies did not stimulate transcription.
DISCUSSION
We have been examining the role of DNA topology in the enhancement of RNA polymerase HI gene expression. Our findings suggested that supercoiled DNA templates containing a pol IE gene were transcribed in vitro at a higher rate and to a greater extent than their linear counterparts (10, 11) . Then we showed that higher levels of transcription from linear DNA molecules can be achieved if the long terminal repeat (LTR) of the mouse mammary tumor virus (MMTV) was co-incubated with the transcription template (8) . Specifically, stimulation occured when the LTR was located within the same construct (in cis) or on a different molecule (in trans). The enhancement in trans was intriguing since it suggested that a trans-acting factor may be mediating the transcriptional stimulation. We suggested that this factors) was a general repressor of in vitro expression in our system and that the LTR titrated it away from the transcription template thereby relieving inhibition (8) . We wanted to identify the sequence harbored within the LTR that promoted transcriptional enhancement. The results of this study demonstrate that a sequence located between nucleotides +3 and +43 relative to the transcription start site of the LTR mediates the in trans enhancement of pol HI gene expression. Using our numbering system, these nucleotides are identified as 1228 to 1268 respectively. This sequence stimulated expression from both the methionine tRNA gene and the somatic-type 5S RNA gene (Ye and Kmiec, unpublished results).
The long terminal repeat contains a number of regulatory regions that participate in the control of gene expression. Among these is the hormone response element or HRE to which the activated receptor binds, setting in motion a cascade of molecular events leading to the initiation of transcription. The HRE and the binding site for nuclear factor I (NFI) are covered by a positioned nucleosome (5) . The relative orientation of various DNA sequences near the HRE site is modulated by the position of the helix as it traverses the nucleosome. This, in turn, determines the accessibility of trans-acting factors for their cognate binding sites (7) . The phased nucleosome is evident by in vivo (6) measurements and in vitro reconstitution reactions (7). The upstream nucleosome, known as nucleosome B, covers the DNA sequence -190 to -45 (7). Another positioned nucleosome is located between nucleotides +25 and +170 respectively and is often referred to as nucleosome A (7). By these structural parameters, the region that we have identified ( + 3/+43) would localize predominantely in the linker region between nucleosomes B and A. The region contains a high number of repetitive T residues, but it is not apparent that these sequences would adopt a unique structure, thereby attracting the factor. Although the features responsible for nucleosome phasing are not established, distorted DNA structure (bent DNA), if applicable, is positioned on the dyad axis of the nucleosome (B), not within the linker region. No such DNA sequence exists within the tRNA gene nor its adjacent spacer (20) and thus a specific DNA binding site, even determined by structure, seems not to be a mechanistic explanation for the transcriptional enhancement we observe.
Clues to a possible explanation for our results may lie in the biochemical properties of the purified protein; (1) it binds preferentially to a specific region on the LTR which lies partially between phased nucleosomes, (2) it does not protect that region specifically as measured by chemical or nuclease DNA footprinting techniques (in fact, the DNA appears undigestable even at high concentrations of DNase I), (3) gel retardation experiments reveal progressively higher molecular weight complexes forming as a function of increasing amounts of purified protein, (4) the protein preferentially aggregates DNA molecules containing the DNA +3 to +43 sequence of the MMTV-LTR. Taken together, these data suggest that the factor may bind preferentially to a linker region in chromatin and aggregate DNA. Coupled with its capacity to block the transcriptional enhancement provided by this sequence (see Figure 8 ), we believe that the factor may influence gene expression in a fashion that has not yet been attributed to the LTR. hi short, IFl may art as a general repressor of gene expression in Xenopus oocytes, but when the +3/+43 sequence or a similar sequence is available, it is titrated and removed from the reaction. The targeted, repressed genes then acquire a transcriptionally permissive phenotype.
Our purified protein bears marked resemblance to histone HI at many different levels. Firstly, the apparent molecular weights of IFl and Xenopus laevis histone HI are quite similar (31,000 daltons) as judged by SDS-PAGE (21). Secondly, both proteins display a high affinity for DNA and under certain reaction conditions can promote DNA aggregation (22) . Thirdly, both proteins can associate with regions of chromatin that are not bound by core nucleosomes; the linker region. Finally, both proteins can repress in vitro transcription, presumably by reducing the accessibility of the DNA template or sterically precluding the binding of trans-acting factors. There are however marked differences between the two activities. Histone HI has not been shown to aggregate preferentially certain DNA sequences; IFl promotes aggregation of DNA molecules that contain the +3/+43 element, although at higher protein concentrations other DNA molecules can be condensed into a detectable network. For example, the sequence of the tRNA gene and spacer does not contain the +3/+43 DNA binding element, yet under our reaction conditions the molecules are aggregated (Table 1) . Histone HI is soluble in 5% perchloric acid while IFl is not. Finally, monoclonal antibodies raised against histone HI (17, 18) fail to cross-react with IFl and do not cause a supershift when added to a IFl-DNA band shift assay. These antibodies are known to recognize a common epitope on HI histone and Hl-like proteins from a variety of species.
The biological function of this protein is currently unknown and will be elucidated only after exhaustive molecular analysis. One can envision a role for proteins that mediate DNA aggregation in the process of chromosomal condensation prior to cell division. DNA compaction might result in the cessation of transcriptional activity and although this form of gene regulation may appear somewhat nonspecific, it is nonetheless effective. For example, the formation of nucleohistone and nucleoprotamine particles in spermatogenesis is sequence directed and quite specific (23) . These investigators reported that sequence specific packaging occurs in the assembly of human sperm chromatin and postulated such sites may designate sites for DNA condensation events. Although the sperm system may be unique, such a general phenomenon could transcend through various cell types, particularly those involved in embryonic development. Our findings may provide the basis for an extended examination of the role of putative repressor proteins in regulating eukaryotic gene expression. The possibility that IF1 or a related protein exists in mouse cell lines (where the MMTV-LTR is most influential) is currently under investigation. It is possible that IF1 may be a known protein (HI) that is modified during development and these alterations mediate its differential activities. Recently, Kharrat et al. (24) demonstrated a role for histone HI and nucleolin in the process of mitotic chromosomal condensation. The synergistic effects of histone HI and nucleolin depend on the site specific phosphorylation of their homologous /3-spiral protein domains. 
